Papillomaviruses are epitheliotropic double-stranded circular DNA viruses responsible for a wide range of skin and mucocutaneous tumors in humans and other animals. The DNA of specific human papillomaviruses (HPVs) (in particular HPV type 16 [HPV16] and HPV18) is found almost regularly in cervical carcinomas, mostly integrated into the host cell genome (49) . Viral early genes E6 and E7 are transcribed in tumor tissue and tumor-derived cell lines (39, 47) . Both E6 and E7 possess transforming potential in vitro (2, 26, 31, 32) , are required for the maintenance of the transformed phenotype of cervical cancer cells (44, 45) , and form specific complexes with the putative tumor suppressor gene products p53 (E6) and Rb (E7) (19, 46) . These findings strongly suggest that E6 and E7 play an important role in the process of malignant transformation.
HPV18 E6-E7 transcription is controlled by cis-acting elements contained in the viral upstream regulatory region (URR), which separates the viral early (E) and late (L) genes in the viral genome (Fig. 1) . The 825-bp viral URR has been functionally divided into three parts (see Fig. 4 ): a 5'-terminally located 389-bp E6-responsive enhancer, a central 230-bp constitutive enhancer, and a 206-bp 3'-terminally located E2-responsive region (22) . However, although a number of studies indicated involvement of cellular factors in HPV gene regulation (12, 14, 15, 20, 23, 24) , host control of viral transcription is still poorly understood.
In the course of experiments designed to characterize cis elements involved in HPV18 transcriptional regulation, we recently identified within the constitutive enhancer a binding site (AATTGCAT, nucleotide [nt] 7721 to 7728) for the ubiquitously expressed Oct-1 transcription factor (8 Protein-protein interactions also seem to play an important role in the functional cooperativity between Oct-1 and steroid receptors, inducing the mouse mammary tumor virus promoter (7) .
To study the influence of Oct-1 on transcription regulated by the HPV18 URR in vivo, we utilized transient expression assays employing the highly sensitive and readily testable luciferase reporter system (6, 17) . Basically, this procedure consists of the introduction of an expression vector (encoding Oct-1 or mutant forms thereof) together with a plasmid containing HPV regulatory sequences linked to the Photinus pyralis luciferase gene. Transcriptional activation by the entire HPV18 URR was studied employing reporter plasmid p18URRL, in which the URR was cloned directly upstream of the P. pyralis luciferase-coding sequence (Fig. 1) . To validate its use as a suitable reporter construct to measure HPV18 URR E6-E7 promoter activity, we determined pi8URRL activity in cultured cells of different origins. As shown in Fig. 1 (37) , which contains the firefly P. pyralis luciferase gene (17) fused to the SV40 poly(A) signal derived from pBLCAT2 (29) and cloned into the polylinker of Bluescript KSM13+ (Stratagene). p18URRL (indicated below) contains the complete HPV18 URR (nt 6929 to 88, numbering according to reference 12) with a 16-bp 3'-terminal deletion removing the E6 ATG to prevent a possible translational interference with the luciferase start codon. Luciferase assays were performed after transfection (11) of HeLa cells, C33 cells (a human cervical carcinoma cell line devoid of HPV sequences), Fib (early-passage human dermal fibroblasts derived from oral mucosa), SV80 cells (SV40-immortalized human fibroblasts), and HepG2 (human hepatocarcinoma cells). Each transfection contained 10 jig of p18URRL and 4 ,ug of pAc-Gal (4.3-kb EcoRI-AluI fragment of the human P-actin promoter [28] linked to the Escherichia coli 3-galactosidase gene) as an internal control and was adjusted to 20 ,ug by the addition of Bluescript DNA. Luciferase activities were quantitated as described previously (6), and P-galactosidase activities were measured (30) to account for variation in transfection efficiency. Promoter activities were determined by calculating the luciferase/p-galactosidase ratios. pl8URRL luciferase activities (fold enhancement above activity of parental plasmid pBL) within different cells are indicated to the right. [17] nt 105 to 124), and the assay was performed essentially as described previously (30) . Products were analyzed on an 8% polyacrylamide sequencing gel, using HpaII-digested pBR322 DNA as the size markers (numbers on left in nucleotides). Lane Fig. 1]) . Coexpression of Oct-1 strongly reduced the amount of correctly initiated transcripts (Fig. 3, lane 2) , confirming that repression occurred at the transcriptional level.
Activity of pi8URRL was also strongly down-modulated by pCGOct-lH- (Fig. 2) , indicating that Oct-1 binding to DNA is not required for this regulatory effect. In contrast, control vector pCGOct-1AS did not significantly affect p18URRL. As a further control, we cotransfected pCGOct-1, pCGOct-lH-, and pCGOct-1AS together with basic vector pBL and did not observe any effect on basal luciferase activity (Table 1) .
We next examined whether the Oct-i-mediated repression is also observed for other transcriptional control regions of different viral and cellular origins. Cotransfection of a constant amount of pCGOct-1 or pCGOct-lH-did not affect luciferase activity controlled by the truncated herpes sim- [29] in ptkL, by the human cytomegalovirus enhancer-promoter region (HincII-AvaII fragment [5] ) in pCMV-Luc, by the human 13-actin promoter (same fragment as pAc-Gal; see the legend to Fig. 1 ) in pAc-Luc, the SV40 early control region encompassing a single 72-bp repeat and the viral early promoter in pSV40-Luc (pBHE [1] ), and by the hydroxymethylglutaryl-coenzyme A reductase promoter (1.4-kb Not-PvulI fragment [21] ) in pHMG-Luc.
plex virus tk gene promoter in ptkL, the human cytomegalovirus promoter in pCMV-Luc, the promoter of the cellular housekeeping gene hydroxymethylglutaryl-coenzyme A reductase in pHMG-Luc, and the human P-actin promoter in pAc-Luc (Table 1 ). In contrast, the HPV18 URR in pi8URRL was down-regulated about 90% by both Oct-1 and Oct-lH-. At the concentrations used in these experiments, we did not observe nonspecific effects of the expression vectors on any of the examined regulatory regions, since cotransfection of control plasmid pCGOct-1AS did not affect the luciferase activities of the respective reporter constructs ( Table 1) .
The activity of the simian virus 40 (SV40) early control region in pSV40-Luc was repressed by Oct-i (Table 1) . However, in contrast to the repression observed for the HPV18 URR, down-modulation of the SV40 enhancer element required binding of Oct-1 to its cognate DNA motif since it was relieved by the homeobox mutation in Oct-lH-.
HeLa cells contain multiple copies of integrated HPV18 sequences and express viral transforming genes E6 and E7 (39) . Both E6 and E7 possess transcriptional activation potential, and E6 was reported to transactivate the homologous HPV18 enhancer (22, 36) . To investigate whether the Oct-i-mediated down-modulation of the HPV18 URR in HeLa cells is dependent on virus-specific gene products, we tested HPV-negative cell lines for Oct-1 repressor function. Both C33 cervical carcinoma cells and primary human dermal fibroblasts exhibited HPV18 URR trans-repression by Oct-1 that was qualitatively and quantitatively comparable to that of HeLa cells ( Table 2 ), indicating that Oct-1 repressor function does not depend on HPV18 gene products. Since Oct-1 repressor function is also observed in human fibroblasts, the results further indicate that Oct-1 repressor function is not confined to epithelial cells (C33, HeLa). To localize the HPV18 cis element(s) conferring repression by Oct-1, we tested different deletion mutants of pi8URRL cotransfected with the Oct-1, Oct-lH-, and OctiAS expression vectors (Fig. 4) . Deletion of HPV18 sequences 6929 to 7509 from pi8URRL (Fig. 4) resulted in plasmid p436/18L, which thus contains the 230-bp RsaI-RsaI constitutive enhancer linked to the homologous promoter region. As indicated, removal of the putative E6-responsive enhancer decreased luciferase activity to about 80% of that of undeleted pi8URRL. However, p436/18L could be efficiently repressed by Oct-1 and Oct-lH-. Deletion of nt 6929 to 7582 from pi8URRL led to a further 71% decrease in HPV18 enhancer activity (p363/18L), but the residual activity could still be efficiently repressed by Oct-i and Oct-iH- (Fig. 4) . Further deletion (nt 6929 to 7713) yielded plasmid p232/18L (Fig. 4) , which was almost inactive (1.8-fold stimulation above that of pBL) and therefore could not be evaluated in Oct-1 repression assays. From these experiments, it can be concluded that Oct-1 repression is mediated by cis elements located in HPV18 sequences 7583 to 88.
To further map the Oct-1 target element(s), we investigated whether HPV18 enhancer elements could confer down-modulation by Oct-1 independent of their homologous promoter region. As shown in Fig. 4 , the 230-bp RsaI-RsaI constitutive enhancer cloned upstream of the heterologous tk promoter (p230s/tkL) was efficiently repressed by both Oct-1 and Oct-lH-. Deletion of a 22-bp 3'-terminal AflIIRsaI fragment containing the Oct-i-binding site (nt 7721 to 7728) resulted in plasmid p208s/tkL. p208s/tkL luciferase activity was strongly inhibited by Oct-1 and Oct-lH-, which is consistent with the observation that Oct-1 binding to DNA is not required for repression. Deletion of a 73-bp 5'-terminal fragment from the 230-bp constitutive enhancer region resulted in pl57s/tkL, which was efficiently repressed by both Oct-1 and Oct-iH- (Fig. 4) . The same 157-bp region also conferred Oct-1 repression when tested in the antisense configuration (pl57as/tkL). Further deletion of a 22-bp 3'-terminal fragment from pi57s/tkL resulted in pl35s/tkL. pl35s/tkL and the corresponding antisense construct pi35as/ tkL were both strongly down-modulated by Oct-1 and Oct-1H- (Fig. 4) (Luc) or cloned in enhancer configuration upstream of the truncated herpes simplex virus tk promoter into ptkL (see Table 1 ). 5' and 3' boundaries of the HPV18 URR fragments (nucleotide numbering according to reference 13) are indicated. DNA manipulations followed standard cloning protocols (30) , and constructs were confirmed by DNA sequencing. All experiments were performed in duplicate and repeated between 3 and 11 times. First column to the right, relative luciferase activities after transfection of 10 ,ug of reporter plasmid (fold activation above that of pBL or ptkL). Second and third columns, percent repression of luciferase activity after cotransfection with 0.5 ,ug of pCGOct-1 and pCGOct-lH-, respectively. n.d., not determined. degenerate octamer sequences within the repressible 135-bp enhancer region, we performed gel retardation assays using Oct-lH-protein (obtained by overexpression in HeLa cells) and the 135-bp fragment as probes. We did not detect binding of Oct-lH-to the HPV18 sequences (25) , suggesting a more indirect mechanism of Oct-i-mediated repression which possibly involves protein-protein contacts. Consistent with this interpretation, Oct-1 has been shown before to possess an intrinsic ability to form protein-protein contacts with heterologous factors such as the herpes simplex virus transactivator VP16 (27, 40) . Repression of the HPV18 enhancer could thus involve squelching (36) by Oct-1 complex formation with an essential HPV18 stimulatory factor, titrating out the number of activator molecules available for HPV transcriptional stimulation.
By deletion mapping, we identified a 135-bp fragment within the HPV18 constitutive enhancer as being sufficient to confer Oct-1 repressor function. This subregion contains several protein-binding sites protected in footprint experiments (12, 20) . With the exception of a member of the AP1 family, however, the other factors binding to this subregion are not yet identified. We also observed Oct-i-mediated repression of the structurally related HPV16 constitutive enhancer (p7463-7752SVE-cat [15] ), also involving a mechanism independent of Oct-1 binding to DNA (25) .
Oct-1 repressor function exhibited specificity for HPV regulatory sequences, since the activity of other transcriptional control regions from other, both cellular (hydroxymethylglutaryl-coenzyme A reductase, actin) and viral (herpes simplex virus, cytomegalovirus), genes was not modulated by Oct-1. In this series of experiments, the only regulatory region also affected by Oct-1 was the SV40 early control region, containing a single 72-bp enhancer repeat and the SV40 early promoter. This finding confirms a previous observation reporting repression of the SV40 enhancer by Oct-1 through competitive binding to an octamer motif which overlaps with an activating Sph motif (42 (16, 45) , it will also be interesting to determine the biological effects of an inducible Oct-1 expression system stably introduced into HPV-positive cervical carcinoma cell lines.
The failure of an intracellular surveillance system controlling HPV transforming gene expression has been implicated to play a key role in HPV-associated carcinogenesis (4, 48, 49) . Consistent with this view, recent reports related a deregulated E6-E7 expression to the development of HPVassociated malignancies (9, 14, 23, 34, 38, 44, 45) . Although one has to be aware that cotransfection assays can involve an unphysiological overexpression of effector proteins, the results obtained in this study provide an experimental basis to investigate a cellular control mechanism that can specifically down-modulate HPV18 enhancer activity, which in turn affects the regulation of viral E6-E7 transforming gene expression. This mechanism could play an important role in the intracellular surveillance of viral gene expression and makes the human homeodomain Oct-1 protein a candidate protein involved in host cell control of HPV transcription.
